from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3159c/PPE53

LFCtreatmentdescriptionclass of inhibitor

-0.533

Amikacinug/mL Amikacintranslation

-0.294

Cap5-10ug/mL Capreomycintranslation

-0.323

Rox10-50 ug/mL Roxithromycintranslation

-0.527

SM2-5 ug/mL Streptomycintranslation

-1.379

Tet5-10 ug/mL Tetracyclinetranslation

0.620

Rif0.2-5ug/mL Rifampicintranscription

-0.036

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.474

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.134

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.575

CPZ10-50 ug/mL Chlorpromazinerespiration

1.590

Clofazimine10-13 ug/mL Clofaziminerespiration

0.757

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.446

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.167

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.059

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.212

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.215

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.111

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.410

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.032

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.210

KCN5-20 ug/mL Potassium cyaniderespiration

-0.421

NaN30.2-2 mM Sodium aziderespiration

-0.806

Nigericin50 uM Nigericinrespiration

1.882

TRC10-150 ug/mL Triclosanrespiration

1.266

TRZ10-25 ug/mL Thioridazinerespiration

-0.916

Valinomycin0.5-10 uM Valinomycinrespiration

-0.579

ZnSO42 mM ZnSO4respiration

-0.502

menadione6-10 ug/mL Menadionerespiration

0.317

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.025

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.083

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.559

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.491

NRP_1Non-replicating persistence stage 1dosRassociated

-0.357

Amp0.2mg/mL AmpicillincellWall

0.120

Cephalexin20-100 ug/mL CephalexincellWall

0.156

Cerulenin0.32-5 ug/mL CerulenincellWall

0.315

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.251

EMB10-20 ug/mL EthambutolcellWall

-0.733

Eta12-40 ug/mL EthionamidecellWall

-0.942

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.244

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.864

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.701

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.516

BZA0.12 mg/mL BenzamidearomaticAmides

-0.561

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.751

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.434

H2O24 mM hydrogen peroxideDNAdamaging

-0.118

Levo10 ug/mL LevofloxacinDNAdamaging

-0.807

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.043

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.577

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.181

UVUV-irradiationDNAdamaging

0.853

ARP41-4 ug/mL Antitubercular compound ARP4?

0.030

Antimycin12.5-50 ug/mL Antimycin A?

-0.593

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.344

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.012

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.707

PA8240.2-2 ug/mL PA-824?

0.197

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.240

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.951

Verapamil50 uM Verapamil?

-0.338

mercaptoethanol2 mM 2-Mercaptoethanol?

0.363

methoxatin10-20 ug/mL Methoxatin?